Inflammatory disorders

FDA approves Wezlana for multiple inflammatory diseases

The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.

Genetics

Novel cause of brain mosaicism and focal epilepsy identified

In most people, every cell in their body contains the same genetic information. However, sometimes people can have two or more genetically different sets of cells. This usually happens during fetal development and is known ...

page 8 from 40